|
44
Дерматовенерология и эстетическая меДицина № 3/2015
ultrasonography combined with power Doppler:
a cross-sectional study // arthr. rheum.
2003;48(2);523–33.
50. De Simone C., Caldarola G., D’agostino m. et
al. usefulness of ultrasound imaging in detecting
psoriatic arthritis of fingers and toes in patients
with psoriasis // Clin. Dev. Immunol. 2011. Vol. 8.
51. Eder I., Gladman V., Pellet F. et. al. Humon
leucocyte antigen risk alleles for psoriatic
arthritis among patients with psoriasis // ann
rheum. Dis. 2012; 71–5.
52. Eder l. et al. Obesity is associated with a
lower probability of achieving sustained minimal
disease activity state among patients with
psoriatic // ann rheum Dis. 2015;74;813–817.
53. Elizabeth G., araujo, Stephanie Finzel, matthias
Englbrecht, Dominik a Schreiber, Francesca
Faustini, axel Hueber, Kemal nas, juergen
rech, Georg Schett High incidence of disease
recurrence after discontinuation of disease-
modifying antirheumatic drug treatment in
patients with psoriatic arthritis in remission et al.
// ann rheum Dis. 2015;74;655–660.
54. Gisondi P., Tinazzi I., Del Giglio m., Girolomoni
G. The diagnostic and therapeutic challenge of
early psoriatic arthritis // Dermatology. 2010;221;
Suppl. 1;6–14.
55. Gisondi P., Tinazzi I., El-Dalati et al. lower
limb enthesopathy in patients with psoriasis
without clinical signs of arthropathy: a hospital-
based case-control study // ann. rheum. Dis.
2008;67(1);26–30.
56. Gisondi P., Tinazzi I., Del Giglio m., Girolomoni
G. The diagnostic and therapeutic challenge of
early psoriatic arthritis // Dermatology. 2010;221
Suppl 1:6–14.
57. Gossec l., Smolen j.S., Gaujoux-Viala C. et
al. European league against rheumatism
recommendations for the management of
psoriatic arthritis with pharmacological therapies
// ann rheum Dis. 2012;71(1);4–12.
58. Gladman D.D. et al. Psoriaticarthritis: epidemio-
logy, clinicalfeatures, courseandoutcome // ann.
rheum. Dis. 2005. Vol. 64, (Suppl. 2). Р. 14–17.
59. Gladman D.D., Farewell V.T. The role of Hla
antigens as indicators of disease progression in
psoriatic arthritis. multivariate relative risk model
// arthr. rheum. 1995;38(6);845.
60. Gulliver W., Tomi Z., macDonald D.
Comorbidities associated with soriasis in the
newfoundland and labrador founder population
// j. am. acad. Dermatol. 2009. P. 501.
61. Gisondi P., Tinazzi I., Del Giglio m., Girolomoni
G. The diagnostic and therapeutic challenge of
early psoriatic arthritis // Dermatology. 2010;221;
Suppl. 1;6–14.
62. Helliwell Ph. Classification criteria for psoriatic
arthritis. 1st World Psoriasis and Psoriatic arthritis
Conference. 2006. Stockholm. 2006. P. 97.
63. Hitchon C.F., Peschken C.a., Shaikh S. et al.
Early undifferentiated arthritis. // rheum Dis Clin
north am. 2005;31;605–26.
64. Hoff m. et al. Prevalence and incidence rates of
psoriatic arthritis in central norway: data from
the nord-Trondelag Health Study (HunT) // ann
rheum Dis. 2015;74;60–64.
65. john b., Sabine l., ashley b.-a. et. al. PTPn
22 is associated with susceptibility to psoriatic
arthritis but not psoriasis: evidence for a further
Psa-specific risk locus // ann rheum Dis.
2015;0;1–4.
66. Kane D., Stafford l., bresnihan b., Fitz Gerald
O. a prospective, clinical and radiological study
of early psoriatic arthritis: an early synovitis
clinic experience // rheumatology (Oxford).
2003;42(12);1460–8.
67. Kaeley G.S. review of the use of ultrasound
for the Diagnosis and monitoring of Enthesitisin
Psoriatic arthritis // Curr. rheumatol. rep. 2011.
Vol. 10.
68. Kristensen S.l. et al. Psoriasis, psoriatic
arthritis and cardiovascular risk: are we closer
to a clinical recommendation? // ann rheum Dis
February. 2015. Vol. 74.
69. love T.j., Zhu y., Zhang y. et al. Obesity and
the risk of psoriatic arthritis: a population-based
study // ann rheum Dis. 2012;71;1273–7.
70. lin H.W., Wang K.H., lin H.C. Increased risk
of acute myocardial infarction in patients with
psoriasis: a 5-year population-based study in
Taiwan // j am acad Dermatol. 2011;64(3);495–
501.
71. mandl P. et al. Eular recommendations for the
use of imaging in the diagnosis and management
of spondyloarthritis in clinical practice // ann
rheum Dis. 2015;0;1–13.
72. marsal S., armadans-Gil l., martinez m. et al.
Clinical, radiographic and Hla associations
asmarkers for different patterns of psoriatic
arthritis // rheumatology (Oxford). 1999;38(4);332.
73. maejima H., Taniguchi T., Watarai a., Katsuoka
K. Evaluation of nail disease in psoriatic arthritis
by using a modified nail psoriasis severity score
index // Int. j. Dermatol. 2010. Vol. 49 (8).
P. 901–906.
74. mease P.j. Psoriatic arthritis: update on
pathophysiology, assessment and management
// ann rheum Dis. 2011. Suppl 1;i77–84.
75. mease Pj. measures of psoriatic arthritis:
Tender and Swollen joint assessment, Psoriasis
area and Severity Index (PaSI), nail Psoriasis
Severity Index (naPSI), modified nail Psoriasis
Severity Index (mnaPSI), mander/newcastle
Enthesitis Index (mEI), leeds Enthesitis Index
(lEI), Spondyloarthritis research Consortium
of Canada (SParCC), maastricht ankylosing
Spondylitis Enthesis Score (maSES), leeds
Dactylitis Index (lDI), Patient Global for Psoriatic
Do'stlaringiz bilan baham: |
